BARONI, GIANNA
BARONI, GIANNA
Scienze della Salute (DSS)
A Fast and Automated Melanin-bleaching Method for Histopathologic Evaluation of Pigmented Melanoma Tissues
2022 Ugolini, Filippo; Baroni, Gianna; Nassini, Romina; De Logu, Francesco; Massi, Daniela
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma
2022 Pastorino, Lorenza; Dalmasso, Bruna; Allavena, Eleonora; Vanni, Irene; Ugolini, Filippo; Baroni, Gianna; Croce, Michela; Guadagno, Antonio; Cabiddu, Francesco; Andreotti, Virginia; Bruno, William; Zoppoli, Gabriele; Ferrando, Lorenzo; Tanda, Enrica Teresa; Spagnolo, Francesco; Menin, Chiara; Gangemi, Rosaria; Massi, Daniela; Ghiorzo, Paola
Baseline β-catenin, programmed death-ligand 1 expression and tumour-infiltrating lymphocytes predict response and poor prognosis in BRAF inhibitor-treated melanoma patients
2017 Massi D; Romano E, Rulli E, Merelli B; Nassini R, De Logu F, Bieche I, Baroni G; Cattaneo L, Xue G, Mandalà M.
Bright-Field Multiplex Immunohistochemistry Assay for Tumor Microenvironment Evaluation in Melanoma Tissues
2022 Ugolini, Filippo; Pasqualini, Elisa; Simi, Sara; Baroni, Gianna; Massi, Daniela
CDX-2 homeobox gene expression.
2003 FRANCHI A; BARONI G; MASSI D; M. SANTUCCI
Cervix adenocarcinoma and squamous cell carcinoma: 2 different morphologicentities?
1999 Taddei G.L.; Raspollini M.R.; Moncini D.; Baroni G.; Buccoliero AM.
Differential HLA class I subunit (A, B, C heavy chain and β2-microglobulin) expression levels in normal tissues
2023 Ugolini, Filippo; Szumera-Ciećkiewicz, Anna; Baroni, Gianna; Nesi, Gabriella; Mandalà, Mario; Ferrone, Soldano; Massi, Daniela
Epstein-Barr virus infection and p53 expression in HIV-related oral large B cell lymphoma
1999 A. Calzolari; A. Papucci; G. Baroni; G. Ficarra; B. Porfirio; I. Chiarelli; S. Di Lollo
Extra-mammary Paget's disease. An HPV-correlated neoplasia?
1993 Taddei G.L.; Moncini D.; Cattaneo A.; Carli P.; Baroni G.
Fascin-1 is a Novel Prognostic Biomarker Associated with Tumor Invasiveness in Adrenocortical Carcinoma.
2019 Poli G, Ruggiero C, Cantini G, Canu L, Baroni G, Armignacco R, Jouinot A, Santi R, Ercolino T, Ragazzon B, Assie G, Mannelli M, Nesi G, Lalli E, Luconi M.
HPV and p53 in urinary bladder carcinoma.
1994 Mincione GP;Messerini L;Saltutti C;Di Cello V;Dominici A;Giannelli E;Baroni G;Calzolari A
Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder.
2005 Raspollini M.R.; Nesi G.; Baroni G.; Girardi L.R.; Taddei G.L.
Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma.
2015 D Massi; L Simi; E Sensi; G Baroni; G Xue; C Scatena; A Caldarella; P Pinzani; G Fontanini; A Carobbio; C Urso; M Mandalà.
Inducible nitric oxide synthase expression in human colorectal cancer - Correlation with tumor angiogenesis
2003 F. Cianchi; C. Cortesini; O. Fantappie; L. Messerini; N. Schiavone; A. Vannacci; S. Nistri; I. Sardi; G. Baroni; C. Marzocca; F. Perna; R. Mazzanti; P. Bechi; E. Masini
Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis
2009 Moretti S, Fabbri P, Baroni G, Berti S, Bani D, Berti E, Nassini R, Lotti T, Massi D.
LH/hCG-Receptor Expression May Have a Negative Prognostic Value in Low-Risk Endometrial Cancer
2016 Noci, Ivo; Sorbi, Flavia; Mannini, Luca; Projetto, Elisabetta; Pillozzi, Serena; Ghizzoni, Viola; Lottini, Tiziano; Moncini, Daniela; Baroni, Gianna; Mungai, Francesco; Arcangeli, Annarosa; Fambrini, Massimiliano
Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer.
2007 Riccardo Bartoletti; Tommaso Cai; Gabriella Nesi; Lucia Roberta Girardi; Gianna Baroni; Maurizio Dal Canto
Multidrug resistance in ovarian cancer: comparing an immunocytochemical study and ATP-tumor chemosensitivity assay.
2002 P. PINZANI; M. PAZZAGLI; G. BARONI; A. TADDEI; G. AMUNNI; A. VILLANUCCI; G. TADDEI; M. RASPOLLINI
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma
2018 Audrito, Valentina; Managò, Antonella; La Vecchia, Sofia; Zamporlini, Federica; Vitale, Nicoletta; Baroni, Gianna; Cignetto, Simona; Serra, Sara; Bologna, Cinzia; Stingi, Aureliano; Arruga, Francesca; Vaisitti, Tiziana; Massi, Daniela; Mandalà, Mario; Raffaelli, Nadia; Deaglio, Silvia
Overexpression of helper T cell type 2-related molecules in the skin of patients with eosinophilic dermatosis of hematologic malignancy
2022 Maglie R.; Ugolini F.; De Logu F.; Nassini R.; Simi S.; Nardiello P.; Pasqualini E.; Baroni G.; Del Bianco E.; Massi D.; Antiga E.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Fast and Automated Melanin-bleaching Method for Histopathologic Evaluation of Pigmented Melanoma Tissues | 2022 | Ugolini, Filippo; Baroni, Gianna; Nassini, Romina; De Logu, Francesco; Massi, Daniela | |
| Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma | 2022 | Pastorino, Lorenza; Dalmasso, Bruna; Allavena, Eleonora; Vanni, Irene; Ugolini, Filippo; Baroni, Gianna; Croce, Michela; Guadagno, Antonio; Cabiddu, Francesco; Andreotti, Virginia; Bruno, William; Zoppoli, Gabriele; Ferrando, Lorenzo; Tanda, Enrica Teresa; Spagnolo, Francesco; Menin, Chiara; Gangemi, Rosaria; Massi, Daniela; Ghiorzo, Paola | |
| Baseline β-catenin, programmed death-ligand 1 expression and tumour-infiltrating lymphocytes predict response and poor prognosis in BRAF inhibitor-treated melanoma patients | 2017 | Massi D; Romano E, Rulli E, Merelli B; Nassini R, De Logu F, Bieche I, Baroni G; Cattaneo L, Xue G, Mandalà M. | |
| Bright-Field Multiplex Immunohistochemistry Assay for Tumor Microenvironment Evaluation in Melanoma Tissues | 2022 | Ugolini, Filippo; Pasqualini, Elisa; Simi, Sara; Baroni, Gianna; Massi, Daniela | |
| CDX-2 homeobox gene expression. | 2003 | FRANCHI A; BARONI G; MASSI D; M. SANTUCCI | |
| Cervix adenocarcinoma and squamous cell carcinoma: 2 different morphologicentities? | 1999 | Taddei G.L.; Raspollini M.R.; Moncini D.; Baroni G.; Buccoliero AM. | |
| Differential HLA class I subunit (A, B, C heavy chain and β2-microglobulin) expression levels in normal tissues | 2023 | Ugolini, Filippo; Szumera-Ciećkiewicz, Anna; Baroni, Gianna; Nesi, Gabriella; Mandalà, Mario; Ferrone, Soldano; Massi, Daniela | |
| Epstein-Barr virus infection and p53 expression in HIV-related oral large B cell lymphoma | 1999 | A. Calzolari; A. Papucci; G. Baroni; G. Ficarra; B. Porfirio; I. Chiarelli; S. Di Lollo | |
| Extra-mammary Paget's disease. An HPV-correlated neoplasia? | 1993 | Taddei G.L.; Moncini D.; Cattaneo A.; Carli P.; Baroni G. | |
| Fascin-1 is a Novel Prognostic Biomarker Associated with Tumor Invasiveness in Adrenocortical Carcinoma. | 2019 | Poli G, Ruggiero C, Cantini G, Canu L, Baroni G, Armignacco R, Jouinot A, Santi R, Ercolino T, Ragazzon B, Assie G, Mannelli M, Nesi G, Lalli E, Luconi M. | |
| HPV and p53 in urinary bladder carcinoma. | 1994 | Mincione GP;Messerini L;Saltutti C;Di Cello V;Dominici A;Giannelli E;Baroni G;Calzolari A | |
| Immunohistochemistry in the differential diagnosis between primary and secondary intestinal adenocarcinoma of the urinary bladder. | 2005 | Raspollini M.R.; Nesi G.; Baroni G.; Girardi L.R.; Taddei G.L. | |
| Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma. | 2015 | D Massi; L Simi; E Sensi; G Baroni; G Xue; C Scatena; A Caldarella; P Pinzani; G Fontanini; A Carobbio; C Urso; M Mandalà. | |
| Inducible nitric oxide synthase expression in human colorectal cancer - Correlation with tumor angiogenesis | 2003 | F. Cianchi; C. Cortesini; O. Fantappie; L. Messerini; N. Schiavone; A. Vannacci; S. Nistri; I. Sardi; G. Baroni; C. Marzocca; F. Perna; R. Mazzanti; P. Bechi; E. Masini | |
| Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis | 2009 | Moretti S, Fabbri P, Baroni G, Berti S, Bani D, Berti E, Nassini R, Lotti T, Massi D. | |
| LH/hCG-Receptor Expression May Have a Negative Prognostic Value in Low-Risk Endometrial Cancer | 2016 | Noci, Ivo; Sorbi, Flavia; Mannini, Luca; Projetto, Elisabetta; Pillozzi, Serena; Ghizzoni, Viola; Lottini, Tiziano; Moncini, Daniela; Baroni, Gianna; Mungai, Francesco; Arcangeli, Annarosa; Fambrini, Massimiliano | |
| Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer. | 2007 | Riccardo Bartoletti; Tommaso Cai; Gabriella Nesi; Lucia Roberta Girardi; Gianna Baroni; Maurizio Dal Canto | |
| Multidrug resistance in ovarian cancer: comparing an immunocytochemical study and ATP-tumor chemosensitivity assay. | 2002 | P. PINZANI; M. PAZZAGLI; G. BARONI; A. TADDEI; G. AMUNNI; A. VILLANUCCI; G. TADDEI; M. RASPOLLINI | |
| Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma | 2018 | Audrito, Valentina; Managò, Antonella; La Vecchia, Sofia; Zamporlini, Federica; Vitale, Nicoletta; Baroni, Gianna; Cignetto, Simona; Serra, Sara; Bologna, Cinzia; Stingi, Aureliano; Arruga, Francesca; Vaisitti, Tiziana; Massi, Daniela; Mandalà, Mario; Raffaelli, Nadia; Deaglio, Silvia | |
| Overexpression of helper T cell type 2-related molecules in the skin of patients with eosinophilic dermatosis of hematologic malignancy | 2022 | Maglie R.; Ugolini F.; De Logu F.; Nassini R.; Simi S.; Nardiello P.; Pasqualini E.; Baroni G.; Del Bianco E.; Massi D.; Antiga E. |